BRAND_ANALYSIS#MODERNAHEALTH & PHARMA#10 OF 26 IN HEALTH & PHARMAINTERESTING
Moderna
· Public · Updated 23 Aug 2026 07:27 UTC
#316 of 1208 overall by tension · #10 of 26 in Health & Pharma
17Interesting
The Silent Giant
Analysis
mRNA's celebrity scientist: 50/67, 0.00 sentiment, +154.52% stock. Moderna soared as a COVID savior, now it's just another pharma company with stock volatility and brand amnesia.
IN THE NEWS (100 articles this week)
Moderna shares surge after it says experimental mRNA cancer treatment passed key test - PBS
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial - STAT
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial - The American Journal of Managed Care